// App-Quantinova.ai

3798 : A glycan-binding malaria protein provides therapeutic access to cisplatin-resistant bladder cancer

Researchers

Presenter

  • HTOO ZARNI OO

Principal Investigators

  • Roland Seiler

  • Sherry S. Lee

  • Davide Tortora

  • Gunjan Kumar

  • Chris Wang

  • Thomas M. Clausen

  • Mette . Agerbk

  • Jamie R. Rich

  • John S. Babcook

  • Peter C. Black

  • Ali Salanti

  • Mads Daugaard

Medical Centers

  • University of British Columbia, Vancouver, British Columbia, Canada.

  • University of Copenhagen, Copenhagen E, Denmark

  • Centre for Drug Research and Development, Vancouver, British Columbia, Canada.

Locations

  • Canada

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Malaria

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved